← Eichor
Study identifier: NCT06989892 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial

Condition: The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD · End Stage Kidney Disease (ESRD) · Sepsis  ·  Sponsor: Navamindradhiraj University

PhaseNA
Planned participants202
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.

This description comes directly from the study's public registry record.

Talk to the study team

Punnawit Laungchuaychok, MD  ·  022443000  ·  punnawit@nmu.ac.th

Wanjak Pongsittisak, MD  ·  022443000  ·  wanjak@nmu.ac.th

Always discuss trial participation with your own doctor first.

Locations (1)

Navamindhradhiraj universityDusit, Bangkok, ThailandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06989892